Improving Graft Outcomes for the Long Term
Presented for attendees of the American Transplant Congress.
This is not an official function/event of the American Transplant Congress.
Accreditation and Designation of Credit
This
activity has been planned and implemented in accordance with the Essential
Areas and Policies of the Accreditation Council for Continuing Medical
Education through the joint sponsorship of the University of Massachusetts
Medical School and Strategically Speaking, Inc. The University of
Massachusetts Medical School is accredited by the ACCME to provide
continuing medical education for physicians.
The
University of Massachusetts Medical School designates this continuing
medical education activity for a maximum of 1 AMA PRA Category 1
Credit™. Physicians should only claim credit commensurate with the
extent of their participation in the activity.
Fee Information and Acknowledgement
There
is no fee for this educational activity, which is supported by an
unrestricted educational grant from Novartis Pharmaceuticals
Corporation.
Evaluation Form (How to obtain your credit/certificate) Please
complete the enclosed evaluation form upon conclusion of the meeting in
order to receive your continuing education credit(s). CME/CE/CEU
certificates will be issued 6 to 8 weeks from the meeting date.
Disclosure Policy
It
is the policy of the University of Massachusetts Medical School to ensure
fair balance, independence, objectivity, and scientific rigor in all
activities. All faculty participating in CME activities sponsored by the
University of Massachusetts Medical School are required to present
evidence-based data, identify and reference off-label product use, and
disclose all relevant financial relationships with those supporting the
activity or others whose products or services are discussed. Faculty
disclosure will be provided in the activity materials.
Disclosure of Unlabeled Use and Disclaimer
This educational activity may contain
discussion of published and/or investigational uses of agents that are not
indicated by the US Food and Drug Administration. The University of
Massachusetts Medical School, Strategically Speaking, Inc., and Novartis
Pharmaceuticals Corporation do not recommend the use of any agent outside
of the labeled indications.
Participants
have an implied responsibility to use the newly acquired information to
enhance patient outcomes and their own professional development. The
information presented in this activity is not meant to serve as a
guideline for patient management. Any procedures, medications, or other
courses of diagnosis or treatment discussed or suggested in this activity
should not be used by clinicians without evaluation of their patients’
conditions, review of possible contraindications, consideration of
applicable manufacturer’s product information, and comparison with
recommendations of other authorities.
|